SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Müller B) "

Sökning: WFRF:(Müller B)

  • Resultat 61-70 av 930
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  • Aaltonen, T., et al. (författare)
  • Tevatron Run II combination of the effective leptonic electroweak mixing angle
  • 2018
  • Ingår i: Physical Review D. - : AMER PHYSICAL SOC. - 2470-0010 .- 2470-0029. ; 97:11
  • Tidskriftsartikel (refereegranskat)abstract
    • Drell-Yan lepton pairs produced in the process p (p) over bar -> l(+)l(-) + X through an intermediate gamma*/Z boson have an asymmetry in their angular distribution related to the spontaneous symmetry breaking of the electroweak force and the associated mixing of its neutral gauge bosons. The CDF and D0 experiments have measured the effective-leptonic electroweak mixing parameter sin(2) theta(lept)(eff) using electron and muon pairs selected from the full Tevatron proton-antiproton data sets collected in 2001-2011, corresponding to 9-10 fb(-1) of integrated luminosity. The combination of these measurements yields the most precise result from hadron colliders, sin(2)theta(lept)(eff) = 0.23148 +/- 0.00033. This result is consistent with, and approaches in precision, the best measurements from electron-positron colliders. The standard model inference of the on-shell electroweak mixing parameter sin(2) theta(W), or equivalently the W-boson mass M-W, using the ZFITTER software package yields sin(2) theta(W) = 0.22324 +/- 0.00033 or equivalently, M-W = 80.367 +/- 0.017 GeV/c(2).
  •  
62.
  •  
63.
  •  
64.
  •  
65.
  • Ruilope, LM, et al. (författare)
  • Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
  • 2019
  • Ingår i: American journal of nephrology. - : S. Karger AG. - 1421-9670 .- 0250-8095. ; 50:5, s. 345-356
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Background:</i></b> Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. <b><i>Patients and</i></b> <b><i>Methods:</i></b> The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate ≥25 mL/min/1.73 m<sup>2</sup> and albuminuria (urinary albumin-to-creatinine ratio ≥30 to ≤5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level α = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. <b><i>Conclusions:</i></b> FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049.
  •  
66.
  •  
67.
  •  
68.
  • Fenstermacher, M.E., et al. (författare)
  • DIII-D research advancing the physics basis for optimizing the tokamak approach to fusion energy
  • 2022
  • Ingår i: Nuclear Fusion. - : IOP Publishing. - 0029-5515 .- 1741-4326. ; 62:4
  • Tidskriftsartikel (refereegranskat)abstract
    • DIII-D physics research addresses critical challenges for the operation of ITER and the next generation of fusion energy devices. This is done through a focus on innovations to provide solutions for high performance long pulse operation, coupled with fundamental plasma physics understanding and model validation, to drive scenario development by integrating high performance core and boundary plasmas. Substantial increases in off-axis current drive efficiency from an innovative top launch system for EC power, and in pressure broadening for Alfven eigenmode control from a co-/counter-I p steerable off-axis neutral beam, all improve the prospects for optimization of future long pulse/steady state high performance tokamak operation. Fundamental studies into the modes that drive the evolution of the pedestal pressure profile and electron vs ion heat flux validate predictive models of pedestal recovery after ELMs. Understanding the physics mechanisms of ELM control and density pumpout by 3D magnetic perturbation fields leads to confident predictions for ITER and future devices. Validated modeling of high-Z shattered pellet injection for disruption mitigation, runaway electron dissipation, and techniques for disruption prediction and avoidance including machine learning, give confidence in handling disruptivity for future devices. For the non-nuclear phase of ITER, two actuators are identified to lower the L-H threshold power in hydrogen plasmas. With this physics understanding and suite of capabilities, a high poloidal beta optimized-core scenario with an internal transport barrier that projects nearly to Q = 10 in ITER at ∼8 MA was coupled to a detached divertor, and a near super H-mode optimized-pedestal scenario with co-I p beam injection was coupled to a radiative divertor. The hybrid core scenario was achieved directly, without the need for anomalous current diffusion, using off-axis current drive actuators. Also, a controller to assess proximity to stability limits and regulate β N in the ITER baseline scenario, based on plasma response to probing 3D fields, was demonstrated. Finally, innovative tokamak operation using a negative triangularity shape showed many attractive features for future pilot plant operation.
  •  
69.
  • Mishra, A., et al. (författare)
  • Stroke genetics informs drug discovery and risk prediction across ancestries
  • 2022
  • Ingår i: Nature. - : Springer Science and Business Media LLC. - 0028-0836 .- 1476-4687. ; 611, s. 115-123
  • Tidskriftsartikel (refereegranskat)abstract
    • Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry(1,2). Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis(3), and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach(4), we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry(5). Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries.
  •  
70.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 61-70 av 930
Typ av publikation
tidskriftsartikel (828)
konferensbidrag (61)
forskningsöversikt (22)
bokkapitel (3)
rapport (2)
annan publikation (2)
visa fler...
bok (1)
doktorsavhandling (1)
visa färre...
Typ av innehåll
refereegranskat (848)
övrigt vetenskapligt/konstnärligt (74)
Författare/redaktör
Meyer, J. (68)
Mehta, A. (62)
Zhang, Z. (61)
Muller, J. (58)
Muller, K. (56)
Ferencei, J. (55)
visa fler...
Schmitt, S. (54)
Schwanenberger, C. (53)
Klein, M. (52)
Rizvi, E. (51)
Heinzelmann, G. (51)
Laycock, P. (50)
Bruncko, D. (49)
Meier, K. (49)
Naumann, T. (49)
Greenshaw, T. (49)
Kluge, T. (49)
Lendermann, V. (49)
Caron, S. (48)
Lobodzinska, E. (48)
Tsipolitis, G. (48)
Valkar, S. (48)
Brenner, H (48)
Hoffmann, D. (47)
Marshall, R. (47)
Takahashi, T. (47)
Wessels, M. (46)
Ibbotson, M. (46)
Perez, E. (46)
Schoeffel, L. (45)
South, D. (45)
Lebedev, A. (45)
Eckerlin, G. (45)
Goerlich, L. (45)
Herrera, G. (45)
Meyer, H. (45)
Nowak, G. (45)
Traynor, D. (45)
Wagner, J. (45)
Diaconu, C. (44)
Zhokin, A. (44)
Kostka, P. (44)
Andreev, V. (44)
Belousov, A. (44)
Favart, L. (44)
Grab, C. (44)
Pitzl, D. (44)
Robmann, P. (44)
Sloan, T. (44)
Thompson, G. (44)
visa färre...
Lärosäte
Karolinska Institutet (428)
Lunds universitet (209)
Uppsala universitet (151)
Göteborgs universitet (150)
Chalmers tekniska högskola (96)
Umeå universitet (92)
visa fler...
Stockholms universitet (70)
Linnéuniversitetet (44)
Kungliga Tekniska Högskolan (36)
Högskolan Dalarna (24)
Linköpings universitet (22)
Luleå tekniska universitet (17)
Sveriges Lantbruksuniversitet (12)
Högskolan i Skövde (8)
Örebro universitet (7)
Mittuniversitetet (7)
RISE (6)
Malmö universitet (3)
Högskolan i Halmstad (2)
Jönköping University (2)
Södertörns högskola (2)
Karlstads universitet (2)
Marie Cederschiöld högskola (1)
IVL Svenska Miljöinstitutet (1)
visa färre...
Språk
Engelska (928)
Svenska (1)
Tyska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (337)
Medicin och hälsovetenskap (276)
Teknik (40)
Samhällsvetenskap (13)
Lantbruksvetenskap (8)
Humaniora (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy